| |
| |
|
| Insider
Information: |
Scalzo Richard William |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
119,283 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,429,386 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
119,283 |
|
|
| Total
Value |
$3,429,386 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dyne Therapeutics, Inc. |
DYN |
|
2024-03-11 |
119,283 |
2020-09-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
32 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2020-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
11,465 |
11,465 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2021-09-20 |
4 |
AS |
$15.61 |
$5,729 |
D/D |
(367) |
11,098 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2021-09-21 |
4 |
AS |
$16.11 |
$7,926 |
D/D |
(492) |
10,606 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,696 |
27,302 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2022-03-11 |
4 |
AS |
$8.73 |
$2,689 |
D/D |
(308) |
26,994 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2022-06-14 |
4 |
D |
$4.95 |
$1,648 |
D/D |
(333) |
26,661 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2022-09-15 |
4 |
D |
$14.05 |
$4,580 |
D/D |
(326) |
26,335 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2022-09-20 |
4 |
D |
$13.70 |
$11,508 |
D/D |
(840) |
25,495 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
56,495 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2022-12-12 |
4 |
AS |
$10.87 |
$3,391 |
D/D |
(312) |
56,183 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-06-13 |
4 |
OE |
$1.03 |
$41,200 |
D/D |
40,000 |
93,482 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-06-13 |
4 |
AS |
$12.43 |
$532,878 |
D/D |
(41,390) |
53,482 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-06-15 |
4 |
AS |
$12.03 |
$120,300 |
D/D |
(10,000) |
43,482 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-09-12 |
4 |
AS |
$10.41 |
$14,543 |
D/D |
(1,397) |
42,085 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-09-18 |
4 |
AS |
$9.41 |
$12,139 |
D/D |
(1,290) |
40,795 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
89,742 |
130,537 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-12-04 |
4 |
AS |
$12.01 |
$8,179 |
D/D |
(681) |
129,856 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-12-06 |
4 |
AS |
$12.01 |
$22,483 |
D/D |
(1,872) |
127,984 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-12-11 |
4 |
AS |
$10.72 |
$14,794 |
D/D |
(1,380) |
126,604 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
See Remarks |
• – – |
2023-12-14 |
4 |
AS |
$12.02 |
$28,560 |
D/D |
(2,376) |
124,228 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
SVP, Head of Finance & Admin. |
• – – |
2024-01-03 |
4 |
OE |
$1.03 |
$13,390 |
D/D |
13,000 |
137,228 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
SVP, Head of Finance & Admin. |
• – – |
2024-01-03 |
4 |
AS |
$18.81 |
$244,530 |
D/D |
(13,000) |
124,228 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
SVP, Head of Finance & Admin. |
• – – |
2024-01-26 |
4 |
OE |
$1.03 |
$13,390 |
D/D |
13,000 |
137,228 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
SVP, Head of Finance & Admin. |
• – – |
2024-01-26 |
4 |
AS |
$24.34 |
$316,420 |
D/D |
(13,000) |
124,228 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
SVP, Head of Finance & Admin. |
• – – |
2024-02-29 |
4 |
AS |
$27.50 |
$94,298 |
D/D |
(3,429) |
124,228 |
0 |
% |
|
32 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
